Evidence map›Paper›PMID 41889721›Full record

Trial reportFrontiers in nutrition2026

Effects of low-dose medium-chain triglycerides on bowel habit outcomes in Japanese adults prone to constipation: a randomized, double-blind, LCT-controlled crossover trial.

Yuki Otsubo, Haruna Ishikawa, Keiichi Kojima, Shinji Watanabe, Naohisa Nosaka, Tsuneo Matsuike

Abstract readClinical Trial
In one paragraph

Trial report in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yuki OtsuboStrategic Invention R&D, The Nisshin OilliO Group, Ltd., Yokohama, Japan.
Haruna IshikawaStrategic Invention R&D, The Nisshin OilliO Group, Ltd., Yokohama, Japan.
Keiichi KojimaStrategic Invention R&D, The Nisshin OilliO Group, Ltd., Yokohama, Japan.
Shinji WatanabeStrategic Invention R&D, The Nisshin OilliO Group, Ltd., Yokohama, Japan.
Naohisa NosakaStrategic Invention R&D, The Nisshin OilliO Group, Ltd., Yokohama, Japan.
Tsuneo MatsuikeMatsuike Clinic, Tachikawa, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: In Japan, many individuals experience symptoms of constipation. Medium-chain triglycerides (MCTs), composed solely of medium-chain fatty acids, have been suggested to improve bowel movements in athletes. However, most prior studies have assumed high-dose intake for ergogenic purposes, and evidence on the effects of low-dose interventions in generally healthy Japanese adults with a tendency toward constipation remains limited. In this study, we investigated the effects of consuming a small amount of MCTs on bowel movements, subjective abdominal condition, and health-related quality of life (HRQOL) in Japanese adults prone to constipation. Methods: This randomized, double-blind, long-chain triglyceride (LCT)-controlled, crossover trial with a 2-week washout enrolled 88 healthy Japanese adults aged 20-64 years with three to five bowel movements per week. Participants ingested 2 g/day of MCTs and 2 g/day of LCTs for 2 weeks each. Bowel movement indicators, subjective abdominal condition, and HRQOL were measured. Results: Using a statistical model for within-participant comparisons, significant diet effects were observed for the number of days with bowel movements, bowel movement frequency, and stool volume. A Conclusion: Daily intake of even a small amount of MCTs, compared with LCTs, may be helpful in improving bowel movements in Japanese adults prone to constipation. Clinical trial registration: https://center6.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000060455; identifier UMIN000052997.

Indexed as

abdominal conditionbowel movementsconstipationdecanoic acidhealth-related quality of lifemedium-chain fatty acids (MCFAs)medium-chain triglycerides (MCTs)octanoic acid

Identifiers

PMID41889721
PMCPMC13015347

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.